Expand BCTX Menu
BCTX MENU

BCTX Latest Press Releases

-- January 28, 2026 --

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation Globe Newswire 7:30 AM

-- January 27, 2026 --

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients Globe Newswire 7:30 AM

-- January 15, 2026 --

BriaCell Therapeutics Announces Closing of US$30 million Public Offering Globe Newswire 4:05 PM

-- January 13, 2026 --

BriaCell Therapeutics Announces Pricing of $30 million Public Offering Globe Newswire 9:00 PM
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS Patient Globe Newswire 7:30 AM

-- December 18, 2025 --

"Eleven clinical trials that will shape medicine in 2026" - BriaCell Phase 3 Trial Featured in Nature Medicine Globe Newswire 7:30 AM

-- December 10, 2025 --

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS 2025 Globe Newswire 7:30 AM

-- December 9, 2025 --

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout Globe Newswire 7:30 AM

-- December 2, 2025 --

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS 2025 Globe Newswire 7:30 AM

-- November 25, 2025 --

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS 2025 Globe Newswire 7:30 AM

-- November 20, 2025 --

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics Globe Newswire 7:30 AM

-- November 18, 2025 --

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS 2025 Globe Newswire 7:30 AM

-- November 7, 2025 --

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+ at SITC 2025 Globe Newswire 7:30 AM

-- November 4, 2025 --

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+ in Breast and Prostate Cancer Models Globe Newswire 7:30 AM

-- October 22, 2025 --

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer Globe Newswire 7:30 AM

-- October 21, 2025 --

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study Globe Newswire 7:50 AM
BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+ for Breast Cancer Globe Newswire 7:30 AM

-- October 20, 2025 --

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025 Globe Newswire 7:30 AM

-- October 13, 2025 --

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025 Globe Newswire 7:30 AM

-- October 3, 2025 --

BriaCell to Present Bria-OTS+ Preclinical Data at SITC 2025 Annual Meeting Globe Newswire 7:30 AM
Market Data Delayed 15 Minutes